Contribution of the ESSE-RF study to preventive healthcare in Russia
https://doi.org/10.15829/1728-8800-2020-2602
Abstract
The article discusses the role of epidemiological studies in the development of preventive programs through the example of the ESSE-RF study. The most interesting and sometimes unexpected research results are discussed. There is an increase in the prevalence of hypertension and obesity, a decrease in the prevalence of smoking, and an extremely high cardiovascular risk. In conclusion, it is noted that the results do provide an opportunity to assess the population health and the priorities of targeted prevention, which is the most effective. Thus, Galen’s statement is confirmed: “Qui bene diagnoscit — bene curat”.
About the Authors
S. A. Shalnova
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
Moscow
Russian Federation
Moscow
O. М. Drapkina
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
Moscow
Russian Federation
Moscow
References
1. 2018 Demographic and Health Indicators of the Russian Federation. Statistical Digest. Moscow 2019, 253 p. (In Russ.)
2. Russian Longitudinal Monitoring Survey — HSE. (In Russ.) http://www.hse.ru/org/hse/rlms.
3. Shalnova SA, Deev AD, Vikhireva OV, et al. Prevalence of arterial hypertension in Russia. Awareness, treatment and control. Disease prevention and health promotion. 2001;2:3- 7. (In Russ.)
4. Oganov RG, Timofeeva TN, Koltunov IE, et al. Arterial hypertension epidemiology in Russia; the results of 2003-2010 federal monitoring. Cardiovascular Therapy and Prevention. 2011;10(1):9-13. (In Russ.) doi:10.15829/1728-8800-2011-1-9-13.
5. Boytsov SA, Chazov EI, Shlyakhto EV, et al. Epidemiology of cardiovascular diseases in different regions of Russia (ESSERF). The rationale for and design of the study. Preventive medicine. 2013;6:25-34. (In Russ.)
6. Boytsov SA, Balanova YuA, Shalnova SA, et al. Arterial hypertension among individuals of 25–64 years old: prevalence, awareness, treatment and control. By the data from ECCD. Cardiovascular Therapy and Prevention. 2014;13(4):4-14. (In Russ.) doi:10.15829/1728-8800-2014-4-4-14.
7. Balanova YuA, Shalnova SA, Imaeva AE, et al. Prevalence of arterial hypertension, treatment and its effectiveness in Russian Federation (The data of observational study ESSE-RF 2) The Rational Pharmakotherapy in Cardiology. 2019;14(5):450-66. (In Russ.) doi:10.20996/1819-6446-2019-15-4-450-466.
8. Salem H, Hasan DM, Eameash A, et al. Worldwide prevalence of hypertension: a pooled meta-analysis of 1670 studies in 71 countries with 29.5 million participants. JACC. 2018;71(11): Supplement. doi:10.1016/S0735-1097(18)32360-X.
9. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020; 16:223-37. doi:10.1038/s41581-019-0244-2.
10. NCD Risk Factor Collaboration (NCD-RisC) L, Abdeen ZA, Hamid ZA, Abu-Rmeileh NM, Acosta-Cazares B, Acuin C, et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627-2642. doi:10.1016/S0140-6736(17)32129-3.
11. Piché M-E, Poirier P, Lemieux I, Després J-P. Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update. Prog Cardiovasc Dis. 2018;61(2):103-113. doi:10.1016/j.pcad.2018.06.004.
12. Shalnova SA, Deev AD, Balanova YuA, et al. Twenty-year trends in obesity and arterial hypertension and their associations in Russia. Cardiovascular Therapy and Prevention. 2017;16(4):4- 10. (In Russ.) doi:10.15829/1728-8800-2017-4-4-10.
13. Zhernakova YuV, Zheleznova EA, Chazova IE, et al. The prevalence of abdominal obesity in the constituent entities of the Russian Federation and its relationship with socio-economic status, results of an epidemiological study ESSE-RF. Therapeutic archive. 2018;90(10):14-22. (In Russ.) doi:10.26442/terarkh2018901014-22.
14. Balanova YuA, Shalnova SA, Deev AD, et al. Obesity in the Russian population — prevalence and associations with risk factors for chronic noncommunicable diseases. Russian Journal of Cardiology. 2018;23(6):123-30. (In Russ.) doi:10.15829/1560-4071-2018-6-123-130.
15. Timpson NJ, Harbord R, Smith GD, et al. Does Greater Adiposity Increase Blood Pressure and Hypertension Risk? Mendelian Randomization Using the FTO/MC4R Genotype. Hypertension. 2009;54:84-90. doi:10.1161/HYPERTENSIONAHA.109.130005.
16. Hall JE, da Silva AA, do Carmo JM, et al. Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins. J Biol Chem. 2010;285(23):17271-6.
17. Balanova YuA, Shalnova SA, Deev AD, et al. Smoking prevalence in Russia. What has changed over 20 years? Profilakticheskaya Medicina. 2015;18(6):47-52. (In Russ.) doi:10.17116/profmed201518647-52.
18. Studziński K, Tomasik T, Krzysztoń J, et al. Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: an overview of systematic reviews. BMC Cardiovasc Disord. 2019;19(1):11. doi:10.1186/s12872-018-0990-2.
Review
For citations:
Shalnova S.A., Drapkina O.М. Contribution of the ESSE-RF study to preventive healthcare in Russia. Cardiovascular Therapy and Prevention. 2020;19(3):2602. (In Russ.) https://doi.org/10.15829/1728-8800-2020-2602
Views:
2568
Email this article 
